Device Devices

Bond-Prime Automated Stainer

Payments companies reported to CMS as associated with Bond-Prime Automated Stainer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$10Kassociated payments (2023-2025)
19clinicians with associated payments
1company reporting

By year

2023 $1,514
2024 $8,705

Payments reported as associated with Bond-Prime Automated Stainer, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $9,083
Clinical Pathology/Laboratory Medicine $587
Hematology & Oncology $500
Anatomic Pathology $34.16
Dermatopathology (Pathology) $15.06

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Bond-Prime Automated Stainer

These are the largest totals companies reported as associated with Bond-Prime Automated Stainer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Yasodha Natkunam Stanford, CA Anatomic Pathology & Clinical Pathology $4,000.00
Girish Venkataraman Maywood, IL Anatomic Pathology & Clinical Pathology $2,750.00
Brooke Howitt Stanford, CA Anatomic Pathology & Clinical Pathology $1,410.00
Nicholas Ladwig San Francisco, CA Anatomic Pathology & Clinical Pathology $603.00
Elham Khanafshar San Francisco, CA Clinical Pathology/Laboratory Medicine $587.00
Frederick Howard Chicago, IL Hematology & Oncology $500.00
Joaquin Garcia Rochester, MN Anatomic Pathology & Clinical Pathology $85.21
Anil Parwani Columbus, OH Anatomic Pathology & Clinical Pathology $85.21
Roshan Patel Blackfoot, ID Anatomic Pathology & Clinical Pathology $35.02
Susan Wu Oceanside, NY Anatomic Pathology & Clinical Pathology $17.08

Prescribed Bond-Prime Automated Stainer?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.